Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice.

Published in: Clinical and experimental vaccine research (2018)

Results showed that the chitosan nanovaccine with intimin protein may be used as a suitable candidate vaccine against E. coli O157:H7.

Keyphrases